• Government pays homage to Bicycle's 'nuclear' approach to cancer cures Business Weekly Wed, 08 Jul 2026 07:00:00 GMT
• Bicycle Therapeutics (BCYC) CSO executes small RSU tax sell-to-cover trades Stock Titan Tue, 07 Jul 2026 21:00:57 GMT
• BICYCLE THERAPEUTICS (BCYC) CEO executes 7,642-share tax sell-to-cover Stock Titan Tue, 07 Jul 2026 21:00:57 GMT
• Bicycle Therapeutics (BCYC) COO sells 1,412 shares in tax-related trades Stock Titan Tue, 07 Jul 2026 21:00:56 GMT
• Bicycle Therapeutics (BCYC) CFO files sell-to-cover sale of 923 shares Stock Titan Mon, 06 Jul 2026 07:00:00 GMT
• Bicycle Therapeutics (BCYC) executive sells shares to cover RSU tax withholding Stock Titan Mon, 06 Jul 2026 07:00:00 GMT
• Tarsus Pharmaceuticals (TARS) moves 7.5% higher: Will this strength last? MSN Sun, 05 Jul 2026 15:14:23 GMT
• if you invested $1,000 in bicycle therapeutics limited (bcyc) Stock Titan Sat, 04 Jul 2026 04:59:49 GMT
• BCYC (Nasdaq: BCYC) files Rule 144 notice listing RSUs and prior sale Stock Titan Thu, 02 Jul 2026 20:09:46 GMT
• bicycle therapeutics (bcyc) holds gains as shares test resistance near $4.50 - cumulative volume dars.gov.et Thu, 02 Jul 2026 15:48:36 GMT
• layoff tracker: biocryst ends all internal discovery efforts BioSpace Tue, 30 Jun 2026 07:00:00 GMT
• price to earnings forward of bicycle therapeutics plc – nasdaq:bcyc TradingView Sat, 27 Jun 2026 19:34:49 GMT
• price to book forward of bicycle therapeutics plc – nasdaq:bcyc TradingView Sat, 27 Jun 2026 13:18:05 GMT
• enterprise value to ebit forward of bicycle therapeutics plc sponsored adr – fwb:50ba TradingView Sat, 27 Jun 2026 08:24:33 GMT
• bicycle therapeutics plc sponsored adr actuals & estimates (nasdaq:bcyc) TradingView Sat, 27 Jun 2026 05:33:55 GMT
• enterprise value to ebitda forward of bicycle therapeutics plc sponsored adr – fwb:50ba TradingView Sat, 27 Jun 2026 05:27:53 GMT
• enterprise value to revenue forward of bicycle therapeutics plc – nasdaq:bcyc TradingView Sat, 27 Jun 2026 04:23:18 GMT
• price to sales forward of bicycle therapeutics plc – nasdaq:bcyc TradingView Fri, 26 Jun 2026 23:41:51 GMT
• layoff tracker: biogen axes ‘small number’ of apellis roles after $5.6b buy BioSpace Fri, 26 Jun 2026 07:00:00 GMT
• bicycle therapeutics plc (bcyc) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 10:36:58 GMT
• Price-Driven Insight from (BCYC) for Rule-Based Strategy Stock Traders Daily Thu, 25 Jun 2026 07:00:00 GMT
• bicycle therapeutics plc (bcyc) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• Bicycle Therapeutics plc Announces Termination of Janice Bourque from Director Role, Effective June 17, 2026 marketscreener.com Sun, 21 Jun 2026 07:00:00 GMT
• bicycle therapeutics plc (bcyc) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 09:08:39 GMT
• Bicycle Therapeutics (BCYC) AGM approves directors, PwC and pay Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Bicycle Therapeutics shareholders approve all proposals at annual general meeting Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• Bicycle Therapeutics PLC (BCYC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 03:37:19 GMT
• bicycle therapeutics plc (bcyc) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:27:07 GMT
• bicycle therapeutics plc (bcyc) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:07:12 GMT
• bicycle therapeutics plc (bcyc) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 12:19:30 GMT
• bicycle therapeutics plc (bcyc) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 12:19:26 GMT
• bicycle therapeutics plc (bcyc) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 12:12:05 GMT
• bicycle therapeutics plc (bcyc) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 11:46:47 GMT
• layoff tracker: neumora, engene cut staff in cost-saving initiatives BioSpace Tue, 16 Jun 2026 07:00:00 GMT
• bicycle therapeutics plc (bcyc) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• bicycle therapeutics plc (bcyc) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• bicycle therapeutics plc (bcyc) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Bicycle Therapeutics Slips Modestly: Navigating Support and Resistance Levels - Throwback Trade dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• layoff tracker: genentech r&d cuts include longtime top exec BioSpace Fri, 12 Jun 2026 07:00:00 GMT
• layoff tracker: fulcrum axes 85% of staff after walking away from lead asset BioSpace Mon, 08 Jun 2026 07:00:00 GMT
• Bicycle Therapeutics stock rating maintained at outperform by Citizens Investing.com Canada Wed, 03 Jun 2026 07:00:00 GMT
• BCYC Under Pressure: Bicycle Therapeutics Tests Key Support After Sharp Decline - SMA Signal dars.gov.et Tue, 02 Jun 2026 07:00:00 GMT
• layoff tracker: merck continues new jersey cuts, laying off 88 in rahway BioSpace Tue, 02 Jun 2026 07:00:00 GMT
• Bicycle Therapeutics: Trading Below Cash Amid Multiple Uncertainties (NASDAQ:BCYC) Seeking Alpha Mon, 01 Jun 2026 07:00:00 GMT
• bicycle therapeutics: riding toward a new frontier in precision-guided cancer medicines? RTTNews Tue, 26 May 2026 07:00:00 GMT
• bicycle therapeutics sharpens new weaponry to fight bladder cancer Business Weekly Fri, 22 May 2026 09:57:06 GMT
• needham maintains bicycle therapeutics(bcyc.us) with buy rating, maintains target price $15 Moomoo Fri, 22 May 2026 07:00:00 GMT
• bicycle therapeutics presents promising duravelo-2 phase 2 data for zelenectide pevedotin in metastatic urothelial cancer at 2026 ... Minichart Fri, 22 May 2026 06:59:00 GMT
• bicycle therapeutics to present initial duravelo-2 data at 2026 asco annual meeting pharmiweb.com Fri, 22 May 2026 00:04:08 GMT
• bicycle therapeutics presents initial duravelo-2 data showing comparable orr and lower toxicity in muc TradingView Thu, 21 May 2026 21:13:00 GMT
• Bicycle Therapeutics sharpens new weaponry to fight bladder cancer Business Weekly Thu, 21 May 2026 07:00:00 GMT
• duravelo-2 bladder cancer data from bicycle (nasdaq: bcyc) Stock Titan Thu, 21 May 2026 07:00:00 GMT
• bicycle therapeutics to present initial duravelo-2 data at 2026 asco annual meeting Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• bladder cancer drug shows 4x fewer skin side effects than standard care Stock Titan Thu, 21 May 2026 07:00:00 GMT
• bicycle therapeutics’ swot analysis: stock navigates trial delays by investing.com Investing.com Nigeria Tue, 19 May 2026 07:00:00 GMT
• morgan stanley maintains bicycle therapeutics(bcyc.us) with hold rating, cuts target price to $4.45 Moomoo Tue, 19 May 2026 01:14:31 GMT
• bicycle therapeutics plc - depositary receipt (bcyc) price target decreased by 29.27% to 13.17 MSN Mon, 18 May 2026 16:07:40 GMT
• morgan stanley maintains bicycle therapeutics(bcyc.us) with hold rating, cuts target price to $4.45 Moomoo Mon, 18 May 2026 07:00:00 GMT
• triana biomedicines appoints mohan bala as chief operating officer by investing.com Investing.com South Africa Mon, 18 May 2026 07:00:00 GMT
• long focus capital (nasdaq: bcyc) holds 3,310,687 ads (6.6%) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• armistice capital/steven boyd disclose 6.75% stake in bicycle therapeutics (bcyc) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• layoff tracker: takeda cuts 4,500, novartis lays off biomedical research staff BioSpace Fri, 15 May 2026 07:00:00 GMT
• after plunging 20.2% in 4 weeks, here's why the trend might reverse for bicycle therapeutics (bcyc) MSN Fri, 15 May 2026 05:39:42 GMT
• bicycle therapeutics plc - depositary receipt (bcyc) price target decreased by 29.27% to 13.17 MSN Thu, 14 May 2026 15:36:41 GMT
• bicycle therapeutics announces poster presentations at the 2025 asco annual meeting Quantisnow Wed, 13 May 2026 13:46:23 GMT
• citizens maintains bicycle therapeutics plc - depositary receipt (bcyc) market outperform recommendation MSN Mon, 11 May 2026 06:54:05 GMT
• citizens maintains bicycle therapeutics plc - depositary receipt (bcyc) market outperform recommendation MSN Sun, 10 May 2026 22:49:06 GMT
• bicycle therapeutics plc - depositary receipt (bcyc) price target decreased by 29.27% to 13.17 MSN Fri, 08 May 2026 12:22:33 GMT
• layoff tracker: gilead laying off vast majority of arcellx employees BioSpace Fri, 08 May 2026 07:00:00 GMT
• needham reaffirms their buy rating on bicycle therapeutics (bcyc) The Globe and Mail Thu, 07 May 2026 07:00:00 GMT
• Needham Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Maintains Target Price $15 Moomoo Wed, 06 May 2026 07:00:00 GMT
• invus & avicenna holdings in bicycle therapeutics (nasdaq: bcyc) disclosed Stock Titan Mon, 04 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: bicycle therapeutics (bcyc), kymera therapeutics (kymr) and teleflex (tfx) The Globe and Mail Sun, 03 May 2026 02:00:00 GMT
• analysts offer insights on healthcare companies: bausch health companies (bhc), irhythm technologies (irtc) and bicycle therapeuti... The Globe and Mail Sat, 02 May 2026 07:00:00 GMT
• bicycle therapeutics (nasdaq:bcyc) rating lowered to "sell" at wall street zen MarketBeat Sat, 02 May 2026 05:46:40 GMT
• rbc capital maintains bicycle therapeutics(bcyc.us) with hold rating, cuts target price to $5 Moomoo Sat, 02 May 2026 02:31:00 GMT
• a quick look at today's ratings for bicycle therapeutics(bcyc.us), with a forecast between $7 to $15 Moomoo Sat, 02 May 2026 01:29:45 GMT
• truist financial maintains bicycle therapeutics(bcyc.us) with hold rating, cuts target price to $7 Moomoo Sat, 02 May 2026 01:26:04 GMT
• bicycle therapeutics reports promising q1 2026 results, advances nuzefatide for pancreatic cancer, and extends cash runway to 2030... Minichart Fri, 01 May 2026 07:00:00 GMT
• bicycle therapeutics 2026 q1 10-q report: financials, risk factors, and forward-looking statements Minichart Fri, 01 May 2026 07:00:00 GMT
• a quick look at today's ratings for bicycle therapeutics(bcyc.us), with a forecast between $7 to $15 Moomoo Fri, 01 May 2026 07:00:00 GMT
• bicycle therapeutics plc sponsored adr (nasdaq:bcyc) sees significant increase in short interest MarketBeat Fri, 01 May 2026 07:00:00 GMT
• rbc capital maintains bicycle therapeutics(bcyc.us) with hold rating, cuts target price to $5 Moomoo Fri, 01 May 2026 07:00:00 GMT
• truist financial maintains bicycle therapeutics(bcyc.us) with hold rating, cuts target price to $7 Moomoo Fri, 01 May 2026 07:00:00 GMT
• bicycle on the high wire as bosses bestride reshuffle act Business Weekly Fri, 01 May 2026 07:00:00 GMT
• jefferies initiates bicycle therapeutics(bcyc.us) with buy rating, announces target price $12 富途牛牛 Fri, 01 May 2026 03:47:16 GMT
• bicycle therapeutics (nasdaq:bcyc) announces earnings results, misses estimates by $0.25 eps MarketBeat Fri, 01 May 2026 01:59:50 GMT
• bicycle therapeutics 2026 q1 10-q report: financials, risk factors, and forward-looking statements Minichart Thu, 30 Apr 2026 21:50:00 GMT
• bicycle therapeutics price target lowered to $12 from $13 at jefferies TipRanks Thu, 30 Apr 2026 20:35:29 GMT
• bicycle therapeutics reports promising q1 2026 results, advances nuzefatide for pancreatic cancer, and extends cash runway to 2030... Minichart Thu, 30 Apr 2026 19:49:00 GMT
• bicycle (bcyc) reports q1 revenue and progress on oncology thera GuruFocus Thu, 30 Apr 2026 16:46:48 GMT
• bicycle therapeutics share price slips below $5 — is the market missing something? primaryignition.com Thu, 30 Apr 2026 11:47:00 GMT
• bicycle therapeutics plc 1q 2026: revenue $887k, eps ($0.87) — 10-q summary TradingView Thu, 30 Apr 2026 11:21:01 GMT
• bicycle therapeutics plc sponsored adr (nasdaq:bcyc) given consensus recommendation of "moderate buy" by brokerages MarketBeat Thu, 30 Apr 2026 07:07:38 GMT
• Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results BioSpace Thu, 30 Apr 2026 07:00:00 GMT
• Bicycle Therapeutics (BCYC) Q1 2026 Earnings: EPS/Revenue Not Di GuruFocus Thu, 30 Apr 2026 07:00:00 GMT
• Bicycle on the high wire as bosses bestride reshuffle act Business Weekly Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics (nasdaq: bcyc) highlights q1 2026 pipeline, $559m cash Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• bcyc financials: income statement, balance sheet & cash flow Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics reports q1 net loss $60.8m, cash $559.5m with runway into 2030 TradingView Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics (nasdaq: bcyc) trims spend with 30% layoffs, focuses pipeline Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics plc reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics (nasdaq:bcyc) announces earnings results, misses estimates by $0.25 eps MarketBeat Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics q1 revenue drops after partnership terminations TradingView Thu, 30 Apr 2026 07:00:00 GMT
• layoff tracker: passage axes 75% of staff, explores strategic alternatives BioSpace Thu, 30 Apr 2026 07:00:00 GMT
• layoff tracker: mucinex maker hits new jersey with more layoffs BioSpace Thu, 30 Apr 2026 07:00:00 GMT
• bicycle therapeutics (bcyc) loses 19.0% in 4 weeks, here's why a trend reversal may be around the corner MSN Mon, 27 Apr 2026 13:40:45 GMT
• after plunging 20.2% in 4 weeks, here's why the trend might reverse for bicycle therapeutics (bcyc) MSN Mon, 27 Apr 2026 12:16:41 GMT
• bicycle therapeutics plc expected to post a loss of 62 cents a share - earnings preview TradingView Mon, 27 Apr 2026 07:00:00 GMT
• rbc capital downgrades bicycle therapeutics plc - depositary receipt (bcyc) MSN Mon, 27 Apr 2026 04:55:33 GMT
• after plunging 20.2% in 4 weeks, here's why the trend might reverse for bicycle therapeutics (bcyc) MSN Sun, 26 Apr 2026 09:04:57 GMT
• citizens maintains bicycle therapeutics plc - depositary receipt (bcyc) market outperform recommendation MSN Sun, 26 Apr 2026 08:50:09 GMT
• after plunging 20.2% in 4 weeks, here's why the trend might reverse for bicycle therapeutics (bcyc) MSN Sat, 25 Apr 2026 18:10:25 GMT
• bicycle therapeutics - 2026 funding rounds & list of investors Tracxn Sat, 25 Apr 2026 07:16:08 GMT
• rbc capital downgrades bicycle therapeutics plc - depositary receipt (bcyc) MSN Sat, 25 Apr 2026 07:15:40 GMT
• rbc capital downgrades bicycle therapeutics plc - depositary receipt (bcyc) MSN Fri, 24 Apr 2026 17:33:19 GMT
• layoff tracker: tempero winding down following serious adverse event BioSpace Fri, 24 Apr 2026 07:00:00 GMT
• bicycle therapeutics plc - depositary receipt (bcyc) price target decreased by 29.27% to 13.17 MSN Fri, 24 Apr 2026 01:19:56 GMT
• after plunging 20.2% in 4 weeks, here's why the trend might reverse for bicycle therapeutics (bcyc) MSN Fri, 24 Apr 2026 01:05:08 GMT
• bicycle therapeutics (bcyc) loses 19.0% in 4 weeks, here's why a trend reversal may be around the corner MSN Thu, 23 Apr 2026 20:47:21 GMT
• citizens maintains bicycle therapeutics plc - depositary receipt (bcyc) market outperform recommendation MSN Thu, 23 Apr 2026 11:28:25 GMT
• bicycle therapeutics (bcyc) to release quarterly earnings on thursday MarketBeat Thu, 23 Apr 2026 08:22:03 GMT
• bicycle therapeutics (bcyc) schedules 2026 agm with director, pay and auditor votes Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• bcyc financials: income statement, balance sheet & cash flow Stock Titan Wed, 22 Apr 2026 01:26:09 GMT
• Five ASCO studies put Bicycle Therapeutics' cancer drug in focus Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: replimune reduces staff; astellas shutters cell therapy site Fierce Biotech Tue, 21 Apr 2026 07:00:00 GMT
• needham maintains bicycle therapeutics(bcyc.us) with buy rating, maintains target price $15 Moomoo Mon, 20 Apr 2026 14:31:00 GMT
• bicycle cancer drug hits 40% response rate, enters pancreatic trial Stock Titan Mon, 20 Apr 2026 11:00:00 GMT
• Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026 Business Wire Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics doses first patient in pancreatic cancer trial Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics (bcyc) advances epha2 pipeline with promisi GuruFocus Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics reports promising phase 1/2 data for nuzefatide pevedotin in cancer and advances epha2 pipeline at aacr 2026 Minichart Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics updates on nuzefatide pevedotin and epha2 pipeline The Pharma Letter Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics advances epha2 oncology pipeline with new data TipRanks Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics : april 2026 corporate presentation marketscreener.com Mon, 20 Apr 2026 07:00:00 GMT
• bicycle therapeutics: early epha2-targeted data and multi-tumor expansion potential support buy rating and upside to valuation TipRanks Mon, 20 Apr 2026 07:00:00 GMT
Bicycle Therapeutics plc(NASDAQ:BCYC) 
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express...
Website: http://bicycletherapeutics.com
Founded: 2009
IPO Price: $14 (May 23, 2019)
Full Time Employees: 81
CEO: Kevin Lee
Sector: Healthcare
Industry: Biotechnology